ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against Interferon

Clinical trial NCT01621269 · WITHDRAWN

Trial details

NCT number: NCT01621269
Sponsor: Novartis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2013-06-01
Primary completion: 2014-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.